Are a recent string of massive jury awards affecting how corporate general counsel approach litigation?
Awards such as the $8 billion verdict against Johnson & Johnson for Risperdal—which will be appealed, the company said—and the $2 billion Bayer AG/Monsanto Roundup weed killer verdict, later reduced to $86.7 million, have grabbed headlines, and unexpectedly large awards for injuries sustained in trucking accidents and the like also have made news recently.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]